TamtajiORMilajerdiAReinerAsemiZDadgostarEHeidari-SoureshjaniRet al
This work was supported by the Wilmot Cancer Institute Predoctoral Fellowship (G.A.), Wilmot Cancer Institute Pilot Funding (I.S.H.), the American Association for Cancer Research and Breast Cancer Research Foundation (20-20-26-HARR) (I.S.H.), Breast Cancer Coalition of Rochester (I.S.H.), a Sir Henry Wellcome Postdoctoral Fellowship (M.E.K.), and a FNR-CORE grant C21/BM/15796788 (D.B.), and NIH grants R01CA269813 (I.S.H.), R37CA230042 (G.M.D), R24AA022057 (V.V.), R01AA028859 (Y.C.), AI150698 (J.M.), K01CA240533-01A1 (C.L.C.), and R01AR078000 (R.T.D.)
R.MarquesM
It is also from a company I trust
Patients struggling with neuroautoimmune conditions often exhibit multisystem symptoms, including gastrointestinal issues, chemical sensitivities, anxiety, insomnia, and heightened reactivity to supplements or medications, hallmarks that overlap significantly with mast cell activation syndrome (MCAS)